Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
10/2000
10/25/2000EP1045862A1 Polypeptides, dna coding therefor, formulations thereof, and their use in inhibiting factor xii activation
10/25/2000EP1045703A1 Stabilization of lipid:dna formulations during nebulization
10/25/2000EP1045702A1 Methods of controlling cell differentiation and growth using a fusion protein and a drug
10/25/2000EP1045700A1 Oral delivery of nucleic acid vaccines by particulate complexes
10/25/2000EP1045699A1 Genetic immunization with co-delivery of nucleic acid and cytokines in a single vehicle
10/25/2000EP1045697A2 Extension of cellular lifespan, methods and reagents
10/25/2000EP0750626B1 Corpuscles of stannius protein, stanniocalcin
10/25/2000CN1271391A Methods and compositions for therapies using genges encoding secreted proteins such as interferon-beta
10/25/2000CN1271389A Nucleic acid vaccines encoding G protein of respiratory syncytial virus
10/25/2000CN1271384A Method for influencing the P53 linkage in target genes
10/24/2000US6137029 Chimeric gene formed by fusion of the promoter of pepck (p-enolpyruvate carboxyquinase) to the structural gene of human insulin; allows physiologically regulated production of human insulin, in a tissue different from the pancreas
10/24/2000US6136954 Polypeptide which activates transcription in eucaryotic cells in the presence of antibiotic; for analysis of cellular proteins
10/24/2000US6136953 Human antiproliferative polypeptide for the detection of vascular injuries
10/24/2000US6136792 Prostate specific enhancer polynucleotides and methods of use thereof
10/24/2000US6136779 Methods of specifically transcriptionally modulating the expression of gene of interest
10/24/2000US6136603 Oligonucleotides which target the untranslated region of a cytokine receptor gene; for treatment of eosinophil defects such as asthma, rhinitis and dermatitis; wound healing agents; antiinflammatory agents; anticarcinogenic agents
10/24/2000US6136602 Nucleotide sequences which can hybridize to preferential target nucleic acids; for the suppression of the expression of genes associated with antibiotic resistance and the prevention of bacterial infections
10/24/2000US6136596 Cytokine-, stress-, and oncoprotein-activated human protein kinase kinases
10/24/2000US6136594 Expression plasmid with defects in gene associated with propagation but which codes cystic fibrosis transmembrane conductance regulator; for gene therapy
10/24/2000US6136581 Kinase genes and uses
10/24/2000US6136572 Recombinant KAT enzyme and process for its preparation
10/24/2000US6136560 Amidotransferase, ratB, of streptococcus pneumoniae
10/24/2000US6136556 TCTS response regulator
10/24/2000US6136548 Mutating one or more amino acids of tissue plasminogen activator, then measuring binding of mutant to beta amyloid peptide and to fibrin; improved mutant binds fibrin but does not bind beta-amyloid peptide; for alzheimer's patients
10/21/2000CA2268379A1 Inhibitor ligands directed against a receptor of vascular endothelial growth factor or against its coding sequence, as anti-angiogenics
10/20/2000CA2306355A1 Methods and compositions for treating human cells
10/19/2000WO2000062063A1 Methods for the diagnosis and treatment of metastatic prostate tumors
10/19/2000WO2000061804A1 Tissue-specific and pathogen-specific toxic agents and ribozymes
10/19/2000WO2000061780A1 Compositions and methods for extending life span
10/19/2000WO2000061779A1 49 human secreted proteins
10/19/2000WO2000061774A2 Bone morphogenic proteins
10/19/2000WO2000061772A2 Compositions and methods for generating an immune response utilizing alphavirus-based vector systems
10/19/2000WO2000061756A2 Compounds for immunotherapy and diagnosis of breast cancer and methods for their use
10/19/2000WO2000061754A2 Human proteins and polynucleotides encoding them
10/19/2000WO2000061753A2 Compositions and methods for the treatment and diagnosis of breast cancer
10/19/2000WO2000061747A2 Clasp-2 transmembrane proteins
10/19/2000WO2000061746A1 13 transmembrane protein expressed in prostate cancer
10/19/2000WO2000061744A1 Novel fetal genes
10/19/2000WO2000061742A2 Treatment of cardiac power failure using s100 proteins
10/19/2000WO2000061736A2 Recombinant and mutant marek's disease virus
10/19/2000WO2000061729A2 Regulation of the expression of transcriptional repressor genes using nucleic acid molecules
10/19/2000WO2000061726A1 Composition for the preservation of infectious recombinant adenoviruses
10/19/2000WO2000061630A1 Induction of kidney tubule formation
10/19/2000WO2000061629A1 49 human secreted proteins
10/19/2000WO2000061628A1 49 human secreted proteins
10/19/2000WO2000061627A1 49 human secreted proteins
10/19/2000WO2000061625A1 48 human secreted proteins
10/19/2000WO2000061624A1 48 human secreted proteins
10/19/2000WO2000061623A1 62 human secreted proteins
10/19/2000WO2000061622A2 Genes associated with diseases of the kidney
10/19/2000WO2000061621A2 Flea head, nerve cord, hindgut and malpighian tubule nucleic acid molecules, proteins and uses thereof
10/19/2000WO2000061620A1 49 human secreted proteins
10/19/2000WO2000061617A2 Transiently immortalized cells for use in gene therapy
10/19/2000WO2000061616A1 Fragments of virus protein 2 or 3 of the polyoma virus, used for transporting active ingredients
10/19/2000WO2000061614A2 Uncoupling proteins
10/19/2000WO2000061612A2 Compounds and methods for therapy and diagnosis of lung cancer
10/19/2000WO2000061610A2 Prostate-restricted gene 30p3c8 expressed in prostate cancer
10/19/2000WO2000061602A1 Antisense oligonucleotide modulation of stat3 expression
10/19/2000WO2000061597A1 Antiproliferative activity of g-righ oligonucleotides and method of using same to bind to nucleolin
10/19/2000WO2000061596A1 50 human secreted proteins
10/19/2000WO2000061595A1 The novel antisense-oligos with better stability and antisense effect
10/19/2000WO2000061543A2 Esters of l-carnitine or alkanoyl l-carnitines
10/19/2000WO2000061193A1 Antisense modulation of mdmx expression
10/19/2000WO2000061184A2 Dry formulation for transcutaneous immunization
10/19/2000WO2000061180A2 Products and methods for treating ptp lar related diseases
10/19/2000WO2000061156A2 Methods of treating schizophrenia
10/19/2000WO2000061150A1 Antisense modulation of fas mediated signaling
10/19/2000WO2000061141A2 Methods and compositions for enhancing delivery of therapeutic agents to tissues
10/19/2000WO2000060932A1 Non-human transgenic animal whose germ cells and somatic cells contain a knockout mutation in dna encoding 4e-bp1
10/19/2000WO2000034780A3 METHODS AND COMPOSITIONS USEFUL FOR TARGETING ACTIVATED VITRONECTIN RECEPTOR αvβ¿3?
10/19/2000WO2000034308A3 Protein transduction system and methods of use thereof
10/19/2000WO2000033872A3 Method of and compositions for immunization with the pseudomonas v antigen
10/19/2000WO2000032769A3 Mage-10 or mage-8 derived hla-a2.1-binding oligopeptides
10/19/2000WO2000029550A9 Low oxygen culturing of central nervous system progenitor cells
10/19/2000WO2000019883A9 Compositions and methods of disease diagnosis and therapy
10/19/2000WO2000013702A9 Use of an angiogenic factor for the treatment of microvascular angiopathies
10/19/2000WO2000009070A3 Inhibition of pathogenic processes related to tissue trauma
10/19/2000WO1999067381A9 Treatment of staphylococcus infections
10/19/2000DE19917195A1 New peptide derived from the MUC-1 tumor marker, used to induce a cytotoxic T cell response for treatment or prevention of tumors
10/19/2000DE19917084A1 Inhibiting cell cycle and cell growth, useful e.g. for protecting neuronal cells, by expressing an inhibitor of nuclear factor-kappaB in transdominant negative form
10/19/2000DE19915485A1 Therapie der Herzinsuffizienz Treatment of heart failure
10/19/2000CA2760534A1 Compositions and methods for generating an immune response utilizing alphavirus-based vector systems
10/19/2000CA2372028A1 Flea head, nerve cord, hindgut and malpighian tubule nucleic acid molecules, proteins and uses thereof
10/19/2000CA2371223A1 49 human secreted proteins
10/19/2000CA2371172A1 50 human secreted proteins
10/19/2000CA2370767A1 49 human secreted proteins
10/19/2000CA2370523A1 49 human secreted proteins
10/19/2000CA2370489A1 49 human secreted proteins
10/19/2000CA2370237A1 Methods for the diagnosis and treatment of metastatic prostate tumors
10/19/2000CA2370189A1 48 human secreted proteins
10/19/2000CA2370131A1 62 human secreted proteins
10/19/2000CA2370112A1 Uncoupling proteins
10/19/2000CA2370000A1 Antiproliferative activity of g-righ oligonucleotides and method of using same to bind to nucleolin
10/19/2000CA2369996A1 Compositions and methods for extending life span
10/19/2000CA2369976A1 The novel antisense-oligos with better stability and antisense effect
10/19/2000CA2369578A1 Compounds and methods for therapy and diagnosis of lung cancer
10/19/2000CA2369439A1 Methods of treating schizophrenia
10/19/2000CA2369413A1 Transmembrane protein expressed in prostate and other cancers
10/19/2000CA2369384A1 Prostate-restricted gene 30p3c8 expressed in prostate cancer
10/19/2000CA2369263A1 Methods and compositions for enhancing delivery of therapeutic agents to tissues
1 ... 695 696 697 698 699 700 701 702 703 704 705 706 707 708 709 710 711 712 713 714 715 ... 870